We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Critical Care Diagnostics Market Worth USD 1.29 Billion By 2024

The global critical care diagnostics (CCD) market will grow at a lucrative rate over the next few years to reach USD 1.29 billion by 2024, driven by the rapid awareness and acknowledgment of these tests by physicians and patients, rise in geriatric population and chronic health conditions, use of telehealth services in remote areas, and technological advancements. However, increased cost of molecular diagnostics and shortage of skilled labor to handle new platforms are expected to hinder the industry’s growth. More...
16 Aug 2016

LabCorp to Acquire Sequenom

Laboratory Corporation of America Holdings (LabCorp) (Burlington, NC, USA), a healthcare diagnostics company, and Sequenom, Inc. (San Diego, CA, USA), which is in the business of non-invasive prenatal testing (NIPT) for reproductive health, have entered into a definitive agreement and plan of merger. More...
01 Aug 2016

Global Digital Pathology Market Worth USD 1,052 Million by 2022

The global digital pathology market will reach USD 1,052 million by 2022, driven by the growing popularity of virtual slides over physical slides, technological advancements, and cost-effective products, with North America accounting for the major share. More...
25 Jul 2016

Blood Gas and Electrolyte Analyzer Market Worth USD 636 Million by 2021

The global blood gas analyzer/blood gas and electrolyte analyzer market is expected to grow at a 5-year CAGR of 4.6% from USD 506.9 million in 2016 to USD 636 million by 2021, driven mainly by growing demand for automated and point-of-care blood gas analyzer devices. More...
20 Jul 2016

Cardiac Biomarker Testing Market Reaches $2 Billion

The market for tests using cardiac biomarkers, including cardiac markers used for heart attack detection, and cholesterol and coagulation tests, surpassed $2 billion in 2015. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm. More...
11 Jul 2016

PoC Diagnostics Market Worth $36.96 Billion by 2021

The global Point-of-Care (PoC) diagnostics market is estimated to grow at CAGR of 9.8% from 2016 to 2021 to reach USD 36.96 Billion, driven by the rising prevalence of lifestyle and infectious diseases and growing preference for home healthcare across the world. More...
11 Jul 2016

Agilent Technologies to Acquire Assets of iLab Solutions

Agilent Technologies Inc. (Santa Clara, California, USA) will acquire most of the assets of iLab Solutions, LLC (Boston, Massachusetts, USA), including the company’s technology, intellectual property, product portfolio and employee talent. The acquisition is expected to be completed in early August, subject to local laws and regulations and customary closing conditions. More...
04 Jul 2016
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
INTEGRA BIOSCIENCES AG